Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
- DOI
- 10.1056/nejmoa2300757
- Published
- 2023-10-26
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2300757,
title = {Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis},
author = {Mathew S. Maurer and Parag Kale and Marianna Fontana and John L. Berk and Martha Grogan and Finn Gustafsson and Rebecca R. Hung and Robert L. Gottlieb and Thibaud Damy and Alejandra González-Duarte and Nitasha Sarswat and Yoshiki Sekijima and Nobuhiro Tahara and Mark S. Taylor and Milos Kubanek and Erwan Donal and Tomas Palecek and Kenichi Tsujita and W.H. Wilson Tang and Wen-Chung Yu and Laura Obici and Marcus Simões and Fábio Fernandes and Steen Hvitfeldt Poulsen and Igor Diemberger and Federico Perfetto and Scott D. Solomon and Marcelo Di Carli and Prajakta Badri and Matthew T. White and Jihong Chen and Elena Yureneva and Marianne T. Sweetser and Patrick Y. Jay and Pushkal P. Garg and John Vest and Julian D. Gillmore},
year = {2023},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2300757},
url = {https://doi.org/10.1056/nejmoa2300757}
}RIS
TY - JOUR TI - Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis AU - Mathew S. Maurer AU - Parag Kale AU - Marianna Fontana AU - John L. Berk AU - Martha Grogan AU - Finn Gustafsson AU - Rebecca R. Hung AU - Robert L. Gottlieb AU - Thibaud Damy AU - Alejandra González-Duarte AU - Nitasha Sarswat AU - Yoshiki Sekijima AU - Nobuhiro Tahara AU - Mark S. Taylor AU - Milos Kubanek AU - Erwan Donal AU - Tomas Palecek AU - Kenichi Tsujita AU - W.H. Wilson Tang AU - Wen-Chung Yu AU - Laura Obici AU - Marcus Simões AU - Fábio Fernandes AU - Steen Hvitfeldt Poulsen AU - Igor Diemberger AU - Federico Perfetto AU - Scott D. Solomon AU - Marcelo Di Carli AU - Prajakta Badri AU - Matthew T. White AU - Jihong Chen AU - Elena Yureneva AU - Marianne T. Sweetser AU - Patrick Y. Jay AU - Pushkal P. Garg AU - John Vest AU - Julian D. Gillmore PY - 2023 JO - New England Journal of Medicine DO - 10.1056/nejmoa2300757 UR - https://doi.org/10.1056/nejmoa2300757 ER -
APA
Maurer, M. S., Kale, P., Fontana, M., Berk, J. L., Grogan, M., Gustafsson, F., Hung, R. R., Gottlieb, R. L., Damy, T., González-Duarte, A., Sarswat, N., Sekijima, Y., Tahara, N., Taylor, M. S., Kubanek, M., Donal, E., Palecek, T., Tsujita, K., Tang, W. W., Yu, W., Obici, L., Simões, M., Fernandes, F., Poulsen, S. H., Diemberger, I., Perfetto, F., Solomon, S. D., Carli, M. D., Badri, P., White, M. T., Chen, J., Yureneva, E., Sweetser, M. T., Jay, P. Y., Garg, P. P., Vest, J., & Gillmore, J. D. (2023). Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2300757
Source records
- crossref · retrieved 2026-09-26T21:41:21.323Z